Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes
Conditions
Interventions
The DESMOND-ID programme is an amended version of the original DESMOND structured education programme that supports adults with T2D to self-manage their condition. The original DESMOND programme is ba
Sponsors
University of Ulster (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 18 years of age or older 2. Living in the community 3. Has mild/moderate ID and T2D identified in their clinical notes and by the ID team, GP, practice nurse and Diabetes Nurse Specialist (DSN) The definition of a family/paid carer is someone who is either a family relative or residentialmember of staff who engages in the support of the person with ID. Verbal and/or written consent will be required from people with ID and from carers before they enter the study.
Exclusion criteria
Exclusion criteria: 1. Patients with type 1 diabetes 2. Patients with a severe/profound ID as assessed by the community ID team 3. Inability to communicate 4. Inability to give their verbal and/or written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This pilot randomised trial will enable us to: 1. Examine the feasibility of delivering the DESMOND-ID programme 2. Assess eligibility, attendance levels, recruitment process, loss to follow-up, compliance and Hb1Ac of adults with ID and T2D 3. Determine the acceptability of randomisation to the adults with ID and their family/paid carers, using retention rates as a surrogate for acceptability 4. Determine the appropriateness and the acceptability of the outcome measures to the adults with ID through completion rates, in order to see whether the primary outcome measure (HbA1c) and secondary outcome measures (BMI, waist circumference, blood pressure, lipid profiles, CVD risk score, smoking, alcohol use, exercise, perceptions and severity of beliefs and quality of life) can be collected 5. Determine the appropriateness and the acceptability of the outcome measures for the family/paid carers through completion rates 6. Measure compliance of the trainers in delivering the DESMOND-ID programme 7. Estimate the treatment effect to determine whether this suggests a clinically important effect which will support the conduct of the full trial Timepoints for all outcomes: Baseline (Time 1): Jan/Feb 2015 Intervention: Feb 2015 Focus Groups: April/May 2015 Follow-up (Time 2): May/June 2015 | — |
Countries
United Kingdom
Outcome results
None listed